LAGRASTA, Costanza Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 10.705
AS - Asia 9.115
EU - Europa 6.623
SA - Sud America 1.126
AF - Africa 402
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.999
Nazione #
US - Stati Uniti d'America 10.388
SG - Singapore 3.086
CN - Cina 2.753
VN - Vietnam 1.450
IT - Italia 1.063
IE - Irlanda 1.058
SE - Svezia 991
FI - Finlandia 927
BR - Brasile 868
DE - Germania 729
HK - Hong Kong 618
UA - Ucraina 518
FR - Francia 407
BD - Bangladesh 370
ZA - Sudafrica 269
TR - Turchia 249
NL - Olanda 242
GB - Regno Unito 201
CA - Canada 194
IN - India 127
AT - Austria 126
AR - Argentina 102
RU - Federazione Russa 83
MX - Messico 76
BE - Belgio 73
IQ - Iraq 52
JP - Giappone 50
CZ - Repubblica Ceca 49
PK - Pakistan 48
PL - Polonia 43
EC - Ecuador 42
PH - Filippine 36
CI - Costa d'Avorio 35
KR - Corea 34
CO - Colombia 32
ES - Italia 30
TH - Thailandia 29
UZ - Uzbekistan 28
MA - Marocco 27
ID - Indonesia 25
LT - Lituania 25
VE - Venezuela 24
AU - Australia 18
TW - Taiwan 18
JO - Giordania 16
MY - Malesia 16
IR - Iran 15
SA - Arabia Saudita 15
AZ - Azerbaigian 13
EG - Egitto 13
PY - Paraguay 13
TN - Tunisia 13
UY - Uruguay 13
CL - Cile 12
NP - Nepal 12
BO - Bolivia 11
OM - Oman 11
DZ - Algeria 10
RO - Romania 10
KE - Kenya 9
PE - Perù 9
ET - Etiopia 8
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
CR - Costa Rica 7
HN - Honduras 7
KZ - Kazakistan 7
AL - Albania 6
SN - Senegal 6
EU - Europa 5
QA - Qatar 5
BY - Bielorussia 4
DO - Repubblica Dominicana 4
HU - Ungheria 4
KH - Cambogia 4
LB - Libano 4
PT - Portogallo 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BW - Botswana 3
DK - Danimarca 3
GE - Georgia 3
GT - Guatemala 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
EE - Estonia 2
GR - Grecia 2
IL - Israele 2
MD - Moldavia 2
NG - Nigeria 2
PS - Palestinian Territory 2
SV - El Salvador 2
Totale 27.978
Città #
Singapore 1.611
Ashburn 1.182
Chandler 1.124
Dublin 1.057
San Jose 965
Beijing 656
Jacksonville 636
Dallas 603
Santa Clara 596
Hong Kong 585
Dearborn 474
Ho Chi Minh City 410
Parma 387
Ann Arbor 356
Boardman 342
Hanoi 322
Nanjing 301
New York 297
Johannesburg 251
Los Angeles 231
Izmir 195
Princeton 192
Shanghai 190
Lauterbourg 176
Wilmington 169
San Mateo 156
Munich 143
Helsinki 114
Jinan 112
Vienna 110
Toronto 106
Bremen 97
Nanchang 93
Shenyang 93
São Paulo 89
Buffalo 83
Kunming 78
Hefei 73
Brussels 72
Seattle 72
Hebei 68
Changsha 66
Frankfurt am Main 61
Haiphong 61
Da Nang 58
Des Moines 58
Padova 57
Council Bluffs 55
Columbus 53
Marseille 53
Chicago 52
Jiaxing 50
Milan 50
Guangzhou 49
Houston 48
Turku 48
Woodbridge 48
Moscow 44
Tianjin 44
Brooklyn 42
London 42
Abidjan 35
Hangzhou 35
The Dalles 35
Montreal 33
Tokyo 32
Warsaw 32
Norwalk 30
Rome 30
Zhengzhou 28
Tashkent 26
Tulsa 26
Atlanta 25
Can Tho 25
Denver 25
Fremont 25
Amsterdam 24
Orem 24
Nuremberg 23
Rio Saliceto 23
Boston 22
Haikou 22
Hải Dương 22
Brasília 21
Brno 21
Falkenstein 21
Mexico City 21
Baghdad 20
Bologna 20
Charlotte 20
Kocaeli 20
Rio de Janeiro 20
Leawood 19
Mumbai 19
Belo Horizonte 18
Chennai 18
Curitiba 18
Lahore 18
Phoenix 18
Redmond 18
Totale 16.838
Nome #
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol 285
Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart 275
Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. 270
Cardiac stem cell disease in diabetic cardiomyopathy: perspectives for preventing cardiac morpho-functional remodelling 245
Acute Myocardial Infarction in Humans is Associated with Activation of Programmed Myocyte Cell Death in the Surviving Portion of the Heart 235
Characterization of ABC transporters in epiairway™, a cellular model of normal human bronchial epithelium 218
Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors 217
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 213
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 207
L’autofagia coinvolge i cardiomiociti e le cellule progenitrici nella cardiomiopatia indotta da imatinib mesilato 205
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 204
Afatinib therapy in case of EGFR G724S emergence as resistance mechanism to osimertinib 204
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 200
Preservation of ventricular performance at early stages of diabetic cardiomyopathy involves changes in myocyte size, number and intercellular coupling. 197
Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC 197
Involvement of HER-2/neu and metastasis-related proteins in the development of ileal neuroendocrine tumors 195
Adattamenti del trasporto osmolare speculare al riassorbimento sodico nella fase pre-ipertensiva del modello sperimentale SHR 194
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 194
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 194
Trastuzumab emtansine is active on HER-2 overexpressing NSCLC cell lines and overcomes gefitinib resistance 193
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 191
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart 190
Lymphangiogenesis in genetically determined hypertrophic obstructive cardiomyopathy 189
Isolation and Characterization of Circulating Tumor Cells in Squamous Cell Carcinoma of the Lung Using a Non-EpCAM-Based Capture Method 185
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 182
Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. 181
Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation 180
Oligodendroglioma Cells Lack Glutamine Synthetase and Are Auxotrophic for Glutamine, but Do not Depend on Glutamine Anaplerosis for Growth 178
Arrhythmogenesis in cardiac hypertrophy. An approach from the “in vivo” towards the cellular level 178
Amelioration of cardiac electrical performance following stem cell based regenerative therapies, in infarcted rat heart 176
Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. 175
GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy 174
Aging and heart failure at the cellular and tissue levels. 174
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 174
Repair of chronic myocardial infarction (MI) induced by mobilization of cardiac progenitor cells (CPCs) via local delivery of hapatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1) is not proarrhythmic. 173
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 173
Analysis of If, action potential duration and myocardial fibrosis as biological determinants of arrhythmogenesis in compensated cardiac hypertrophy in rat. 171
Cancer treatment-induced cardiotoxicity: a cardiac stem cell disease? 171
Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice 170
Adattamenti nella regolazione di tonicità midollare renale nella fase preipertensiva del modello sperimentale SHR. 170
Notch expression and bevacizumab efficacy in colorectal cancer patients 170
Apoptotic/mytogenic pathways during human heart development 169
Aging, cardiac hypertrophy and ischemic cardiomyopathy do not affect the proportion of mononucleated and multinucleated myocytes in the human heart 169
Microsfere polimeriche funzionalizzate per terapie rigenerative cardiache mediate da cellule staminali. Test di biocompatibilità in vitro e in vivo. 169
Development and validation of an high performance liquidchromatography–tandem mass spectrometry method for the determination of imatinib in rat tissues 169
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 169
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 169
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 167
Adattamenti del trasporto osmolare speculare al riassorbimento sodico nella fase pre-ipertensiva del modello sperimentale SHR. 167
Mobilization of cardiac progenitor cells by Hepatocyte Growth Factor (HGF) and Insulin-like Growth Factor-1 (IGF-1) for repairing chronic myocardial infarction (MI) is not proarrhytmic. 167
Analysis of IF, action potential duration, and myocardial fibrosis as biological determinants of arrhythmogenesis in compensated cardiac hypertrophy in rat 167
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 167
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 166
Resveratrol Treatment Reduces Cardiac Progenitor Cell Dysfunction and Prevents Morpho-Functional Ventricular Remodeling in Type-1 Diabetic Rats 165
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 163
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 162
Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats 161
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 160
Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease? 159
Assessment of Cardiac Patches Suitability for Tissue Engineering 159
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 158
Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN 158
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico. 157
Article access statistics The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma 157
Dissecting the cellular mechanisms of cardiotoxicity by anthracycline and tyrosine kinase inhibitors 157
ALK and ROS1 rearrangements tested by fluorescence in situ hybridization in cytological smears from advanced non-small cell lung cancer patients 157
Motor responses of rat hypertrophic intestine following chronic obstruction 156
Apoptosis in the Infarcted Human Heart 155
Electro-mechanical competence of regenerated heart in stem cell based therapy of myocardial infarction in rat model. 153
Cardiac electromechanical performance following stem cell based regenerative therapies in infarcted rat heart. 153
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 153
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 152
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 151
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 151
CHARACTERIZATION OF MYOCARDIAL HYPERTROPHY IN PREHYPERTENSIVE SPONTANEOUSLY HYPERTENSIVE RATS: INTERACTION BETWEEN ADRENERGIC AND NITROSATIVE PATHWAYS 150
Body surface maps in chronically instrumented rats. In: . ed, , Amsterdam, 1989, pp 257-260. 149
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 149
Identification and tumorigenic role of Mesenchymal Stem Cells from human lung cancer 147
Resident cardiac stem cells. 146
High-resolution X-ray microtomography for three-dimensional imaging of cardiac progenitor cell homing in infarcted rat hearts 146
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 145
Sex chromosome alterations associate with tumor progression in sporadic colorectal carcinomas. 145
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 144
Recent advances in cardiac hypertrophy 144
Stem cells and myocardial regeneration 143
Apoptotic myocyte cell loss in failing human infarcted heart. 143
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 143
Tyrosine kinase cardiotoxicity: ultrastructural analysis of imatinib mesylate induced cardiomyopathy 142
Time-course transcriptome analysis of a double challenge bleomycin-induced lung fibrosis rat model uncovers ECM homoeostasis-related translationally relevant genes 141
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 141
Phase-contrast microtomography: are the tracers necessary for stem cell tracking in infarcted hearts? 140
Imatinib mesylate induced cardiotoxicity: a cardiac progenitor cell disease? 140
Cardiac electrical activity during social stress 140
Genetic alterations in combined neuroendocrine neoplasms of the lung 139
p73 and p53 pathway in human breast cancers. 139
Caratterizzazione strutturale ed identificazione dei fenotipi staminali della placenta umana 139
Cardiac hypertrophy in humans: myocyte cellular hypertrophy predominates in adulthood and myocyte nuclear hyperplasia in the elderly 137
Development of biomimetic alginate/gelatin/elastin sponges with recognition properties toward bioactive peptides for cardiac tissue engineering 137
Competenza funzionale elettrica del cuore rigenerato mediante mobilizzazione di cellule staminali cardiache residenti, in un modello di ratto con infarto miocardico cronico 137
High-Resolution X-Ray Microtomography for Three-Dimensional Visualization of Cardiac Progenitor Cells Homing in Infarcted Rat Hearts 137
Totale 17.082
Categoria #
all - tutte 93.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022969 34 15 31 44 27 27 137 130 49 86 69 320
2022/20234.180 393 461 320 331 383 487 50 269 1.271 14 144 57
2023/20241.475 77 139 27 32 129 373 149 108 43 90 129 179
2024/20254.551 88 239 314 368 515 460 163 197 526 391 387 903
2025/202610.558 928 916 1.137 951 1.363 558 1.187 335 1.495 779 468 441
Totale 28.186